Rosiglitazone potentiates alveolar bone loss due to ligature-induced periodontitis in rats (2010)
In: Resumos
Conference titles: Congresso Brasileiro de Farmacologia e Terapêutica Experimental
Subjects: FARMACOLOGIA
ABNT
MARTINS PORTO, R.; MAIA-DANTAS, A.; HERRERA, B. S.; et al. Rosiglitazone potentiates alveolar bone loss due to ligature-induced periodontitis in rats. Anais.. Ribeirão Preto: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE, 2010.APA
Martins Porto, R., Maia-Dantas, A., Herrera, B. S., Campi, P., Costa, S. K. P., Nucci, G. de, et al. (2010). Rosiglitazone potentiates alveolar bone loss due to ligature-induced periodontitis in rats. In Resumos. Ribeirão Preto: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE.NLM
Martins Porto R, Maia-Dantas A, Herrera BS, Campi P, Costa SKP, Nucci G de, Spolidório LC, Muscará MN. Rosiglitazone potentiates alveolar bone loss due to ligature-induced periodontitis in rats. Resumos. 2010 ;Vancouver
Martins Porto R, Maia-Dantas A, Herrera BS, Campi P, Costa SKP, Nucci G de, Spolidório LC, Muscará MN. Rosiglitazone potentiates alveolar bone loss due to ligature-induced periodontitis in rats. Resumos. 2010 ;